Tag : Chronic

Cardiology

The Association Between Patient-reported Clinical Factors and 30-day Acute Care Utilization in Chronic Heart Failure.

Newsemia
Related Articles The Association Between Patient-reported Clinical Factors and 30-day Acute Care Utilization in Chronic Heart Failure. Med Care. 2020 Apr;58(4):336-343 Authors: Chen J, Sadasivam...
Latest News

Motor neuropathy with conduction block due to pan‐neurofascin antibodies in a patient with chronic lymphocytic leukemia

Newsemia
Li, V; Schon, F; Fehmi, J; Modarres, H; Rinaldi, S; Rossor, AM; (2020) Motor neuropathy with conduction block due to pan‐neurofascin antibodies in a patient...
Latest News

Moraxella catarrhalis and rhinovirus infection and co-infection of healthy and chronic obstructive pulmonary disease ciliated respiratory epithelium

Newsemia
Velkova, Simona Asenova; (2020) Moraxella catarrhalis and rhinovirus infection and co-infection of healthy and chronic obstructive pulmonary disease ciliated respiratory epithelium. Doctoral thesis (Ph.D), UCL...
Pharma / Biotech

Population pharmacokinetic and exposure-response analysis of eptinezumab in the treatment of episodic and chronic migraine.

Newsemia
Related Articles Population pharmacokinetic and exposure-response analysis of eptinezumab in the treatment of episodic and chronic migraine. Pharmacol Res Perspect. 2020 Apr;8(2):e00567 Authors: Baker B,...
Cardiology

Percutaneous coronary intervention in aorto-ostial coronary chronic total occlusion: outcomes and technical considerations in a multicenter registry.

Newsemia
Related Articles Percutaneous coronary intervention in aorto-ostial coronary chronic total occlusion: outcomes and technical considerations in a multicenter registry. Rev Esp Cardiol (Engl Ed). 2020...
Latest News

Shionogi Announces Launch of Mulpleo® (lusutrombopag) in the UK, for the Treatment of Severe Thrombocytopenia in Adult Patients With Chronic Liver Disease Undergoing Invasive Procedures

Newsemia
OSAKA, Japan & AMSTERDAM–(BUSINESS WIRE)–Shionogi & Co., Ltd. and its European subsidiary, Shionogi B.V. (hereafter “Shionogi”), today announce the launch of Mulpleo® (lusutrombopag) in the...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy